Yahoo
NasdaqGS - Delayed Quote USD

Vertex Pharmaceuticals Incorporated (VRTX)

546.12 -11.84 (-2.12%)
At close: September 4 at 4:00:00 PM EDT
546.00 -0.12 (-0.02%)
After hours: September 4 at 7:51:59 PM EDT
Trade VRTX on Coinbase

News headlines

Updated 1h ago
Powered by Yahoo Scout

Vertex Pharmaceuticals is experiencing strong growth driven by its cystic fibrosis franchise and recent acquisition of Crinetics. Despite some challenges, analysts maintain a positive outlook, with a consensus 'Moderate Buy' rating and a price target indicating potential upside.

Mobilize your Website
View Site in Mobile | Classic
Share by: